The role of IL-1 and IL-1Ra in joint inflammation and cartilage degradation. (Q36617121)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17027524%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

review article

1 reference

title

The role of IL-1 and IL-1Ra in joint inflammation and cartilage degradation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17027524%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17027524%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Marjolaine Gosset

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17027524%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Francis Berenbaum

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17027524%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Cem Gabay

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17027524%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17027524%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

published in

Vitamins and Hormones

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17027524%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17027524%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

371-403

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17027524%20AND%20SRC:MED&resulttype=core&format=json

The effect of IL-1beta on the expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human chondrocytes.

20 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

A disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motifs: the ADAMTS family

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Interleukin-1 receptor antagonist: role in biology

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Reversal of autocrine and paracrine effects of interleukin 1 (IL-1) in human arthritis by type II IL-1 decoy receptor. Potential for pharmacological intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Functional genomic analysis of type II IL-1beta decoy receptor: potential for gene therapy in human arthritis and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Intracellular IL-1 receptor antagonist type 1 inhibits IL-1-induced cytokine production in keratinocytes through binding to the third component of the COP9 signalosome

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Transplantation of transduced chondrocytes protects articular cartilage from interleukin 1-induced extracellular matrix degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Synergistic effect of interleukin-1 beta and tumor necrosis factor alpha on PGE2 production by articular chondrocytes does not involve PLA2 stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

The type II decoy receptor of IL-1 inhibits murine collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Interleukin-1beta and tumor necrosis factor-alpha produce distinct, time-dependent patterns of acute arthritis in the rat knee.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Evidence for the presence of peroxisome proliferator-activated receptor (PPAR) alpha and gamma and retinoid Z receptor in cartilage. PPARgamma activation modulates the effects of interleukin-1beta on rat chondrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

15-Deoxy-delta12,14-PGJ2, but not troglitazone, modulates IL-1beta effects in human chondrocytes by inhibiting NF-kappaB and AP-1 activation pathways.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Lack of response to anakinra in rheumatoid arthritis following failure of tumor necrosis factor alpha blockade.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Cloning, expression analysis, and structural characterization of seven novel human ADAMTSs, a family of metalloproteinases with disintegrin and thrombospondin-1 domains

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Nitric oxide inhibits the synthesis of type-II collagen without altering Col2A1 mRNA abundance: prolyl hydroxylase as a possible target

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

TRAF6 is a signal transducer for interleukin-1

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis. Suppression of collagenase-1 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Metalloproteinase inhibitors and the prevention of connective tissue breakdown

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Nitric oxide attenuates cellular hexose monophosphate shunt response to oxidants in articular chondrocytes and acts to promote oxidant injury

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

The role of nitric oxide in inflammation and immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Gene deletion of either interleukin-1beta, interleukin-1beta-converting enzyme, inducible nitric oxide synthase, or stromelysin 1 accelerates the development of knee osteoarthritis in mice after surgical transection of the medial collateral ligament

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

ADAMTS-8 exhibits aggrecanase activity and is expressed in human articular cartilage

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

The type II 'decoy' receptor: a novel regulatory pathway for interleukin 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Basic biology and clinical application of specific cyclooxygenase-2 inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

The effects of treatment with interleukin-1 receptor antagonist on the inflamed synovial membrane in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Effects of soluble interleukin-1 type II receptor on rabbit antigen-induced arthritis: clinical, biochemical and histological assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

ADAMTS-9 is synergistically induced by interleukin-1beta and tumor necrosis factor alpha in OUMS-27 chondrosarcoma cells and in human chondrocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

The PPARalpha-leukotriene B4 pathway to inflammation control.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Normal cartilage structure, biochemistry, and metabolism: a review of the literature.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Recombinant human interleukin-1 receptor type I in the treatment of patients with active rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Cytokine traps: multi-component, high-affinity blockers of cytokine action

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Interleukin 1 receptor antagonist is a member of the interleukin 1 gene family: evolution of a cytokine control mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Peroxisome proliferator--activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Peroxisome proliferator-activated receptor gamma activators inhibit MMP-1 production in human synovial fibroblasts likely by reducing the binding of the activator protein 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

In vivo transfer of interleukin-1 receptor antagonist gene in osteoarthritic rabbit knee joints: prevention of osteoarthritis progression

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Rapid responses to anakinra in patients with refractory adult-onset Still's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Expression of ADAMTS homologues in articular cartilage

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Increased production of intracellular interleukin-1 receptor antagonist type I in the synovium of mice with collagen-induced arthritis: a possible role in the resolution of arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Intracellular IL-1Ra type 1 inhibits IL-1-induced IL-6 and IL-8 production in Caco-2 intestinal epithelial cells through inhibition of p38 mitogen-activated protein kinase and NF-kappaB pathways.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Direct retrovirus-mediated gene transfer to the synovium of the rabbit knee: implications for arthritis gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Osteoarthritis and cartilage: the role of cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Transcriptional suppression by interleukin-1 and interferon-gamma of type II collagen gene expression in human chondrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Regulation of Collagen Gene Expression by Prostaglandins and Interleukin-1beta in Cultured Chondrocytes and Fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Matrix metalloproteinases: the clue to intervertebral disc degeneration?

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Open label trial of anakinra in active ankylosing spondylitis over 24 weeks

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Chondrocyte apoptosis and nitric oxide production during experimentally induced osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Nitric oxide and proteoglycan biosynthesis by human articular chondrocytes in alginate culture

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Immunolocalisation studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Contribution of cyclopentenone prostaglandins to the resolution of inflammation through the potentiation of apoptosis in activated macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

A nuclear target for interleukin-1alpha: interaction with the growth suppressor necdin modulates proliferation and collagen expression

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Activation of nuclear receptors by prostaglandins

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Expression of alternatively spliced interleukin-1 receptor accessory protein mRNAs is differentially regulated during inflammation and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

The 3' untranslated region of the membrane-bound IL-1R accessory protein mRNA confers tissue-specific destabilization.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

IL-1 signaling cascade in liver cells and the involvement of a soluble form of the IL-1 receptor accessory protein

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Unresponsiveness of MyD88-deficient mice to endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Expression profiling of metalloproteinases and their inhibitors in cartilage

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

The modulation of matrix metalloproteinase and ADAM gene expression in human chondrocytes by interleukin-1 and oncostatin M: a time-course study using real-time quantitative reverse transcription-polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Interleukin-1 beta converting enzyme inhibition blocks progression of type II collagen-induced arthritis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

IL-1 beta protects human chondrocytes from CD95-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Role of nitric oxide, reactive oxygen species, and p38 MAP kinase in the regulation of human chondrocyte apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Different roles of tumour necrosis factor alpha and interleukin 1 in murine streptococcal cell wall arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

ADAMTS-1 cleaves a cartilage proteoglycan, aggrecan

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Detection of nitrotyrosine in aging and osteoarthritic cartilage: Correlation of oxidative damage with the presence of interleukin-1beta and with chondrocyte resistance to insulin-like growth factor 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

The role of interleukin 1 receptor-associated kinase-4 (IRAK-4) kinase activity in IRAK-4-mediated signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Altered susceptibility to collagen-induced arthritis in transgenic mice with aberrant expression of interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Pathophysiological mechanisms in osteoarthritis lead to novel therapeutic strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Interleukin-1 receptor accessory protein interacts with the type II interleukin-1 receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Production of intracellular IL-1alpha, IL-1beta, and IL-1Ra isoforms by activated human dermal and synovial fibroblasts: phenotypic differences between human dermal and synovial fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

The interleukin-1 receptor in normal and osteoarthritic human articular chondrocytes. Identification as the type I receptor and analysis of binding kinetics and biologic function

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Effect of hypoxia and reoxygenation on gene expression and response to interleukin-1 in cultured articular chondrocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Up-regulation of microsomal prostaglandin E synthase 1 in osteoarthritic human cartilage: critical roles of the ERK-1/2 and p38 signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Selective inhibition of inducible nitric oxide synthase exacerbates erosive joint disease

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Enhanced and coordinated in vivo expression of inflammatory cytokines and nitric oxide synthase by chondrocytes from patients with osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Intracellular interleukin-1 receptor antagonist type 1 antagonizes the stimulatory effect of interleukin-1 alpha precursor on cell motility

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Balance of synovial fluid IL-1 beta and IL-1 receptor antagonist and recovery from Lyme arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Cloning and characterization of a new isoform of the interleukin 1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Aggrecanases and cartilage matrix degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Membrane-associated IL-1 contributes to chronic synovitis and cartilage destruction in human IL-1 alpha transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: extension phase of a randomized, double-blind, placebo-controlled

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

PPA250 [3-(2,4-difluorophenyl)-6-[2-[4-(1H-imidazol-1-ylmethyl) phenoxy]ethoxy]-2-phenylpyridine], a novel orally effective inhibitor of the dimerization of inducible nitric-oxide synthase, exhibits an anti-inflammatory effect in animal models of ch

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Intra-articular delivery of a herpes simplex virus IL-1Ra gene vector reduces inflammation in a rabbit model of arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Preliminary results of safety and efficacy of the interleukin 1 receptor antagonist anakinra in patients with severe lupus arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Mice transgenic for intracellular interleukin-1 receptor antagonist type 1 are protected from collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Induction of nitric oxide synthase in human chondrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Therapy and prevention of arthritis by recombinant adeno-associated virus vector with delivery of interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

The human interleukin-1 receptor antagonist (IL1RN) gene is located in the chromosome 2q14 region

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

The increased synthesis of inducible nitric oxide inhibits IL-1ra synthesis by human articular chondrocytes: possible role in osteoarthritic cartilage degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Selective inhibition of inducible nitric oxide synthase reduces progression of experimental osteoarthritis in vivo: possible link with the reduction in chondrocyte apoptosis and caspase 3 level

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

The prodomain of interleukin 1alpha interacts with elements of the RNA processing apparatus and induces apoptosis in malignant cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

The ADAMTS metalloproteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Cartilage protection by nitric oxide synthase inhibitors after intraarticular injection of interleukin-1beta in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Inhibition of interleukin-1-induced effects in synoviocytes transduced with the human IL-1 receptor antagonist cDNA using an adenoviral vector

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Nitric oxide mediates interleukin-1-induced gene expression of matrix metalloproteinases and basic fibroblast growth factor in cultured rabbit articular chondrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

15-deoxy-delta 12,14-prostaglandin J2. A prostaglandin D2 metabolite generated during inflammatory processes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Retinoic acid combines with interleukin-1 to promote the degradation of collagen from bovine nasal cartilage: matrix metalloproteinases-1 and -13 are involved in cartilage collagen breakdown

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

In vivo expression of inflammatory cytokine receptors in the joint compartments of patients with arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

The two interleukin-1 receptors play different roles in IL-1 actions.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Cloning of the genes for human stromelysin and stromelysin 2: differential expression in rheumatoid synovial fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type II IL-1 receptor to inhibit IL-1 action

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Characterization of ADAMTS-9 and ADAMTS-20 as a distinct ADAMTS subfamily related to Caenorhabditis elegans GON-1

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Subcellular localization of prostaglandin endoperoxide H synthases-1 and -2 by immunoelectron microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

The human IL-1 receptor antagonist gene (IL1RN) maps to chromosome 2q14-q21, in the region of the IL-1 alpha and IL-1 beta loci

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

The N-terminal propiece of interleukin 1 alpha is a transforming nuclear oncoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Microsomal prostaglandin E synthase is regulated by proinflammatory cytokines and glucocorticoids in primary rheumatoid synovial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Efficacy of anakinra in active ankylosing spondylitis: a clinical and magnetic resonance imaging study

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Nitric-Oxide Mediates Suppression of Cartilage Proteoglycan Synthesis by Interleukin-1

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Differentiation regulates interleukin-1beta-induced cyclo-oxygenase-2 in human articular chondrocytes: role of p38 mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Characterization of human aggrecanase 2 (ADAM-TS5): substrate specificity studies and comparison with aggrecanase 1 (ADAM-TS4).

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Detection of interleukin-1 in the cartilage of patients with osteoarthritis: a possible autocrine/paracrine role in pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Reduced cartilage proteoglycan loss during zymosan-induced gonarthritis in NOS2-deficient mice and in anti-interleukin-1-treated wild-type mice with unabated joint inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Role of tumour necrosis factor alpha in experimental arthritis: separate activity of interleukin 1beta in chronicity and cartilage destruction

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

Detection of an interleukin-1 intracellular receptor antagonist mRNA variant.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

The precursor form of IL-1alpha is an intracrine proinflammatory activator of transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

MyD88: an adapter that recruits IRAK to the IL-1 receptor complex

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974016-X

7 January 2021

10.1016/S0083-6729(06)74016-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17027524%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference